Bernd Meibohm, Ph.D. is a Distinguished Professor of Pharmaceutical Sciences, Harriet S. Van Vleet Endowed Professor, Associate Dean for Research and Graduate Programs at the College of Pharmacy, and Chair Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, Tennessee, USA. His research interests include pulmonary infectious and inflammatory diseases, pediatric pharmacotherapy and the application of quantitative modeling and simulation techniques in preclinical and clinical drug development, with specific focus on therapeutic proteins. His research work has attracted more than $40 million in extramural funding as principal and co-investigator and has resulted in over 190 scientific papers and book chapters (h-index 53), three textbooks, 180 abstracts, and over 200 invited scientific presentations to national and international audiences. Dr. Meibohm is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and American College of Clinical Pharmacology (ACCP). He is a past president of the American College of Clinical Pharmacology, and is currently serving as associate editor for The AAPS Journal.  

​Johan Gabrielsson, Ph.D. is a Professor of Integrative Pharmacology in Uppsala, Sweden. He served as Senior Principal Scientist at AstraZeneca R&D between 2002-2012. His responsibilities included pre-clinical PK/PD projects in the GI & CV, CNSP, Oncology and Infection areas as well as biological data analysis. He is the author of the textbooks ‘Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications’ 5th ed. (2016) and ‘Quantitative Pharmacology: An Introduction to Integrative PKPD Analysis’ (2012). He has published extensively in the field of pharmacokinetic-pharmacodynamic modelling and reasoning and has run courses in the area of biological data analysis (>6,000 participants) since 1984. He acts as an independent teacher and consultant.